This CPD activity is supported by an unrestricted education grant by Reckitt.[/caption]
Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
E-cigarettes warning after link with pulmonary illness in US
A new statement on e-cigarettes has been issued by the Australian Government Department of Health.
The Australian Government Department of Health has issued a new...
How pharmacists can help diagnose and manage cow’s milk allergy
Awareness is growing about childhood allergies, especially peanut allergy. But according to the Australasian Society of Clinical Immunology and Allergy (ASCIA), the symptoms of...
If catastrophe calls, include these ‘musts’ in your plan
It’s imperative that every pharmacy have a disaster plan, a clear written procedure on what to do, to eliminate delays getting deliveries to affected areas.
The new normal
A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...
Indirect impacts of COVID-19
Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.
Bringing pharmacists into the digital future
PSA has unveiled a new digital health report, Connecting the dots: Digitally empowered pharmacists, at the PSA19 conference.
The report, funded by the Australian Digital...
